Literature DB >> 19955388

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

Julie Kreyenbuhl1, Robert W Buchanan, Faith B Dickerson, Lisa B Dixon.   

Abstract

The Schizophrenia Patient Outcomes Research Team (PORT) project has played a significant role in the development and dissemination of evidence-based practices for schizophrenia. In contrast to other clinical guidelines, the Schizophrenia PORT Treatment Recommendations, initially published in 1998 and first revised in 2003, are based primarily on empirical data. Over the last 5 years, research on psychopharmacologic and psychosocial treatments for schizophrenia has continued to evolve, warranting an update of the PORT recommendations. In consultation with expert advisors, 2 Evidence Review Groups (ERGs) identified 41 treatment areas for review and conducted electronic literature searches to identify all clinical studies published since the last PORT literature review. The ERGs also reviewed studies preceding 2002 in areas not covered by previous PORT reviews, including smoking cessation, substance abuse, and weight loss. The ERGs reviewed over 600 studies and synthesized the research evidence, producing recommendations for those treatments for which the evidence was sufficiently strong to merit recommendation status. For those treatments lacking empirical support, the ERGs produced parallel summary statements. An Expert Panel consisting of 39 schizophrenia researchers, clinicians, and consumers attended a conference in November 2008 in which consensus was reached on the state of the evidence for each of the treatment areas reviewed. The methods and outcomes of the update process are presented here and resulted in recommendations for 16 psychopharmacologic and 8 psychosocial treatments for schizophrenia. Another 13 psychopharmacologic and 4 psychosocial treatments had insufficient evidence to support a recommendation, representing significant unmet needs in important treatment domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955388      PMCID: PMC2800150          DOI: 10.1093/schbul/sbp130

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  22 in total

1.  Updating evidence-based clinical guidelines.

Authors:  Martin Eccles; Nikki Rousseau; Nick Freemantle
Journal:  J Health Serv Res Policy       Date:  2002-04

2.  Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?

Authors:  P G Shekelle; E Ortiz; S Rhodes; S C Morton; M P Eccles; J M Grimshaw; S H Woolf
Journal:  JAMA       Date:  2001-09-26       Impact factor: 56.272

Review 3.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

4.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

5.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

6.  Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

Authors:  A F Lehman; D M Steinwachs
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

Review 7.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

8.  The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

Authors:  Anthony F Lehman; Julie Kreyenbuhl; Robert W Buchanan; Faith B Dickerson; Lisa B Dixon; Richard Goldberg; Lisa D Green-Paden; Wendy N Tenhula; Daniela Boerescu; Cenk Tek; Neil Sandson; Donald M Steinwachs
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

9.  Guideline recommendations for treatment of schizophrenia: the impact of managed care.

Authors:  Barbara Dickey; Sharon-Lise T Normand; Richard C Hermann; Susan V Eisen; Dharma E Cortes; Paul D Cleary; Norma Ware
Journal:  Arch Gen Psychiatry       Date:  2003-04

10.  Measuring the quality of outpatient treatment for schizophrenia.

Authors:  A S Young; G Sullivan; M A Burnam; R H Brook
Journal:  Arch Gen Psychiatry       Date:  1998-07
View more
  127 in total

1.  The field of schizophrenia: strengths, weaknesses, opportunities, and threats.

Authors:  John M Kane; Barbara Cornblatt; Christoph U Correll; Terry Goldberg; Todd Lencz; Anil K Malhotra; Delbert Robinson; Philip Szeszko
Journal:  Schizophr Bull       Date:  2011-11-18       Impact factor: 9.306

2.  Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US.

Authors:  Gary R Bond; Robert E Drake; Deborah R Becker
Journal:  World Psychiatry       Date:  2012-02       Impact factor: 49.548

3.  Lessons learned in developing community mental health care in North America.

Authors:  Robert E Drake; Eric Latimer
Journal:  World Psychiatry       Date:  2012-02       Impact factor: 49.548

4.  Deep concern.

Authors:  Luc Ciompi; Courtenay M Harding; Klaus Lehtinen
Journal:  Schizophr Bull       Date:  2010-05-17       Impact factor: 9.306

5.  A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.

Authors:  Elizabeth Bromley; Gail Fox Adams; John S Brekke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

6.  Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia.

Authors:  Y-T Xiang; G S Ungvari; C U Correll; H F K Chiu; N Shinfuku
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-20       Impact factor: 6.892

7.  The New York City Mental Health Needs Assessment Study (MHNAS): Objectives, design, and methods.

Authors:  Christina C Norman; Kate McDonald; Amanda E Schneider; Igor Malinovsky; Emily Goldmann; Michael K Blauschild; Cynthia Driver
Journal:  Int J Methods Psychiatr Res       Date:  2018-02-02       Impact factor: 4.035

8.  Implementing Effective Policy in a National Mental Health Reengagement Program for Veterans.

Authors:  Shawna N Smith; Zongshan Lai; Daniel Almirall; David E Goodrich; Kristen M Abraham; Kristina M Nord; Amy M Kilbourne
Journal:  J Nerv Ment Dis       Date:  2017-02       Impact factor: 2.254

9.  Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

Authors:  Miguel Camacho-Gomez; Pere Castellvi
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 10.  Cariprazine: A Review in Schizophrenia.

Authors:  Karly P Garnock-Jones
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.